Showing results (11-20 of 27) with videos related to

Sort By:
Pageof 3
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|April 19, 2026
Co-targeting hallmarks of cancer for therapeutic benefit in ovarian cancer: a scoping reviewValentina Iacobelli, Floriana Camarda, Gloria Anderson, et al.
Breast (Edinburgh, Scotland)|February 4, 2026
Predicting progression-free survival in hormone-receptor positive (HR+/HER2-) metastatic breast cancer (MBC) treated with CDK4/6 inhibitors: A machine learning approachSergio Pannunzio, Luca Mastrantoni, Noemi Maliziola, et al.
The Lancet. Oncology|November 14, 2024
Comparison of first-line chemotherapy regimens in unresectable locally advanced or metastatic pancreatic cancer: a systematic review and Bayesian network meta-analysisLuca Mastrantoni, Marta Chiaravalli, Alexia Spring, et al.
Therapeutic Advances in Medical Oncology|June 7, 2023
Adjuvant denosumab in early breast cancer: a systematic review and meta-analysis of randomized controlled clinical trialsLuca Mastrantoni, Giovanna Garufi, Elena Di Monte, et al.
Vaccines|April 23, 2025
COVALENCE STUDY: Immunogenicity and Reactogenicity of a COVID-19 mRNA Vaccine in an Open-Label Cohort of Long-Survivor Patients with Metastatic Lung CancerEmanuele Vita, Federico Monaca, Luca Mastrantoni, et al.
Cancer|March 29, 2024
Symptomatic androgen deficiency and sexual dysfunctions in male patients receiving alectinib for ALK-positive advanced non-small cell lung cancerEmanuele Vita, Federico Monaca, Domenico Milardi, et al.
Acta Paediatrica (Oslo, Norway : 1992)|September 1, 2025
Development and Validation of Multivariable Machine-Learning Models for the Prediction of Multisystemic Inflammatory Syndrome Outcomes in Latin American ChildrenDanilo Buonsenso, Luca Mastrantoni, Rolando Ulloa-Gutierrez, et al.
Clinical Breast Cancer|March 28, 2025
Activity and Efficacy of Neoadjuvant Chemotherapy in Luminal-HER2 Negative Early Breast Cancer According to HER2 Score (Low vs. Score 0): A Retrospective StudyGiovanna Garufi, Luca Mastrantoni, Noemi Maliziola, et al.
Current Oncology (Toronto, Ont.)|August 27, 2025
Bone Health and Endocrine Therapy with Ovarian Function Suppression in Premenopausal Early Breast Cancer: A Real-Life Monocenter Experience with DenosumabAngelachiara Rotondi, Valentina Frescura, Giorgia Arcuri, et al.
Journal of Personalized Medicine|March 27, 2026
Next Frontier in HER2+/HR+ Breast Cancer: Leveraging Cell Cycle Control with CDK4/6 InhibitorsIlaria Poli, Gaia Rachele Oliva, Ginevra Mongelli, et al.
Pageof 3